ONC BeOne Medicines AG

390.94USD-2.19%Mkt Cap: 44.66B USDP/E: 50.12

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products incl…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap44.66B USD
Enterprise Value41.94B USD
Revenue (TTM)6.61B USD
Gross Profit4.67B USD
Net Income (TTM)286.93M USD
Revenue/Share59.12 USD
Last Price390.94 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees12.0K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)50.12
P/E (Forward)35.93
PEG0.71
EV/EBITDA31.56
EV/Revenue6.35
P/S6.76
P/B7.66
EPS (TTM)7.80 USD
EPS (Forward)10.78 USD
52W Range
253.9580% of range424.66
52W High424.66 USD
52W Low253.95 USD
Profitability
Gross Margin87.49%
Oper. Margin17.84%
EBITDA Margin20.11%
Profit Margin5.37%
ROE6.58%
ROA3.50%
ROIC33.95%
ROCE7.03%
Growth
Revenue Growth33.80%
Earnings Growth212.50%
Cash Flow & Leverage
Operating CF1.13B USD
CapEx (TTM)266.53M USD
FCF Margin15.54%
FCF Yield2.30%
Net Debt-3.72B USD
Net Debt/EBITDA-2.80
Net Debt/FCF-3.62
Balance Sheet
Debt/Equity0.25
Current Ratio3.55
Quick Ratio3.10
Book Value/Sh51.01 USD
Cash/Share50.61 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)472.77 USD
Upside (mean)+20.9%
Target Range412.00 USD – 561.30 USD
412.00+20.9% to mean561.30
# Analysts27
Ownership
Shares Out.105.38M
Float81.33M
Insiders17.28%
Institutions34.73%
Short Interest
Short Ratio4.3d
Short % Float1.97%
Short % Out.1.40%
Shares Short1.60M
Short (prev mo.)1.93M
Technical
SMA 50372.52 (+4.9%)
SMA 200328.78 (+18.9%)
Beta0.63
S&P 52W Chg12.00%
Avg Vol (30d)403.02K
Avg Vol (10d)488.15K
Technical Indicators
RSI (14)50.0
MACD9.8100
MACD Signal11.3636
MACD Hist.-1.5536
BB Upper437.96 USD
BB Middle392.65 USD
BB Lower347.34 USD
BB Width23.08%
ATR (14)11.55 USD
Vol Ratio (20d)0.87x

About BeOne Medicines (NASDAQ: ONC)

›

BeOne Medicines (NASDAQ: ONC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 12,000 employees.

The shares were at 390.94 USD on 20 November 2026, up 13.8% over 52 weeks. Its 52-week range is 253.95 USD to 424.66 USD: the price is 7.9% below the high and 53.9% above the low.

At a market capitalisation of 44.66B USD, it trades at 50.1 times trailing earnings and 35.9 times forward earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.1, a premium of 51% for ONC.

BeOne Medicines reports return on equity of 6.6%, an operating margin of 17.8% and revenue up 33.8% year over year.

It holds more cash than debt, a net cash position of 3.72B USD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 27 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 472.77 USD is 20.9% above the current price. The next earnings report is expected on 25 February 2027.